Effect of Apiban Therapy on AVF Maturation in ESRD Patients
NCT07559942
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
190
Enrollment
OTHER
Sponsor class
Conditions
Endstage Renal Disease
Direct Oral Anticoagulants (DOACs)
Arteriovenous Fistula
Arteriovenous Fistula Occlusion
Interventions
DRUG:
Apixaban
Sponsor
Combined military hospital lahore